| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,430,000,000 |
| Market
Cap: |
108.85(B) |
| Last
Volume: |
5,979,028 |
Avg
Vol: |
8,403,954 |
| 52
Week Range: |
$48.64 - $76.12 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 297 |
| Guru Rank Value : 4.1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
319,019 |
515,670 |
1,014,661 |
2,126,174 |
| Total Sell Value |
$23,643,548 |
$35,428,615 |
$61,747,133 |
$111,248,213 |
| Total People Sold |
9 |
10 |
11 |
13 |
| Total Sell Transactions |
15 |
28 |
45 |
80 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Onuscheck John Michael |
SVP & Pres-Neuromodulation |
• – – |
2011-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,628 |
36,389 |
|
- |
|
| Kucheman William |
EVP, & Group Pres, CRV |
• – – |
2011-02-14 |
4 |
D |
$6.97 |
$10,009 |
D/D |
(1,436) |
57,123 |
|
- |
|
| Kucheman William |
EVP, & Group Pres, CRV |
• – – |
2011-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,993 |
58,559 |
|
- |
|
| Pucel Kenneth |
EVP, Global Ops & Technology |
• – – |
2011-02-14 |
4 |
D |
$6.97 |
$12,330 |
D/D |
(1,769) |
74,398 |
|
- |
|
| Pucel Kenneth |
EVP, Global Ops & Technology |
• – – |
2011-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,792 |
76,167 |
|
- |
|
| Phalen Michael P. |
EVP & President, International |
• – – |
2011-02-14 |
4 |
D |
$6.97 |
$8,211 |
D/D |
(1,178) |
32,487 |
|
- |
|
| Phalen Michael P. |
EVP & President, International |
• – – |
2011-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,274 |
33,665 |
|
- |
|
| Pedersen John B. |
Pres, Uro & Womens Health |
• – – |
2011-02-14 |
4 |
D |
$6.97 |
$2,502 |
D/D |
(359) |
639 |
|
- |
|
| Pedersen John B. |
Pres, Uro & Womens Health |
• – – |
2011-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
998 |
998 |
|
- |
|
| Leno Sam R |
EVP & Chief Operations Officer |
• – – |
2011-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,982 |
344,470 |
|
- |
|
| Moreci Stephen F |
SVP, Global Sales Operations |
• – – |
2011-02-14 |
4 |
D |
$6.97 |
$7,507 |
D/D |
(1,077) |
28,555 |
|
- |
|
| Moreci Stephen F |
SVP, Global Sales Operations |
• – – |
2011-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,995 |
29,632 |
|
- |
|
| Lance Jean Fitterer |
SVP & Chief Compliance Officer |
• – – |
2011-02-14 |
4 |
D |
$6.97 |
$8,218 |
D/D |
(1,179) |
55,850 |
|
- |
|
| Lance Jean Fitterer |
SVP & Chief Compliance Officer |
• – – |
2011-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,194 |
57,029 |
|
- |
|
| Burns Brian R |
EVP - Global Quality & Reg Aff |
• – – |
2011-02-14 |
4 |
D |
$6.97 |
$10,009 |
D/D |
(1,436) |
49,939 |
|
- |
|
| Burns Brian R |
EVP - Global Quality & Reg Aff |
• – – |
2011-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,993 |
51,375 |
|
- |
|
| Mario Ernest |
Director |
– • – |
2011-02-07 |
4 |
B |
$6.94 |
$346,990 |
D/D |
50,000 |
131,004 |
2.39 |
- |
|
| Dawkins Keith D |
Sr. VP, Chief Medical Officer |
• – – |
2011-01-07 |
4 |
D |
$7.28 |
$28,195 |
D/D |
(3,873) |
43,846 |
|
- |
|
| Dawkins Keith D |
Sr. VP, Chief Medical Officer |
• – – |
2011-01-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,771 |
47,719 |
|
- |
|
| Johnson Kristina M |
Director |
– • – |
2011-01-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
21,124 |
|
- |
|
| Fitzgerald Joseph Michael |
SVP & President, Endovascular |
• – – |
2011-01-03 |
4 |
D |
$7.60 |
$2,272 |
D/D |
(299) |
43,674 |
|
- |
|
| Fitzgerald Joseph Michael |
SVP & President, Endovascular |
• – – |
2011-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
767 |
43,973 |
|
- |
|
| Onuscheck John Michael |
SVP & Pres-Neuromodulation |
• – – |
2011-01-03 |
4 |
D |
$7.60 |
$1,923 |
D/D |
(253) |
30,761 |
|
- |
|
| Onuscheck John Michael |
SVP & Pres-Neuromodulation |
• – – |
2011-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
588 |
31,014 |
|
- |
|
| Elliott John Raymond |
President and CEO |
• • – |
2010-12-31 |
4 |
D |
$7.57 |
$1,580,268 |
D/D |
(208,754) |
409,510 |
|
- |
|
2009 Records found
|
|
Page 37 of 81 |
|
|
0.23 (0.3%) 
